PL363990A1 - Arylosulfonamidy jako środki przeciwwirusowe - Google Patents

Arylosulfonamidy jako środki przeciwwirusowe

Info

Publication number
PL363990A1
PL363990A1 PL02363990A PL36399002A PL363990A1 PL 363990 A1 PL363990 A1 PL 363990A1 PL 02363990 A PL02363990 A PL 02363990A PL 36399002 A PL36399002 A PL 36399002A PL 363990 A1 PL363990 A1 PL 363990A1
Authority
PL
Poland
Prior art keywords
sup
antiviral agents
arylsulfonamides
substituents
processes
Prior art date
Application number
PL02363990A
Other languages
English (en)
Inventor
Tobias Wunberg
Wolfgang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Jorg Keldenich
Armin Kern
Siegfried Raddatz
Jurgen Reefschlager
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of PL363990A1 publication Critical patent/PL363990A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL02363990A 2001-04-19 2002-04-08 Arylosulfonamidy jako środki przeciwwirusowe PL363990A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
PL363990A1 true PL363990A1 (pl) 2004-11-29

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02363990A PL363990A1 (pl) 2001-04-19 2002-04-08 Arylosulfonamidy jako środki przeciwwirusowe

Country Status (20)

Country Link
US (1) US7115612B2 (pl)
EP (1) EP1383749B1 (pl)
JP (1) JP4480941B2 (pl)
CN (1) CN1516695A (pl)
AT (1) ATE308529T1 (pl)
BG (1) BG108272A (pl)
BR (1) BR0209054A (pl)
CA (1) CA2444123C (pl)
DE (1) DE50204780D1 (pl)
EE (1) EE200300515A (pl)
ES (1) ES2252455T3 (pl)
HU (1) HUP0303813A3 (pl)
IL (1) IL158324A0 (pl)
MX (1) MXPA03009548A (pl)
NO (1) NO20034667L (pl)
PL (1) PL363990A1 (pl)
RU (1) RU2003133750A (pl)
SK (1) SK12662003A3 (pl)
UY (1) UY27263A1 (pl)
WO (1) WO2002085869A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20050168A2 (en) * 2002-08-23 2005-10-31 Rigel Pharmaceuticals Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
DE102006009928A1 (de) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
EP2387995A1 (en) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
CA2692379A1 (en) * 2007-07-02 2009-01-08 Boehringer Ingelheim International Gmbh Antiproliferative compounds based on 5-membered heterocycles
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
CN103119036B (zh) * 2010-06-28 2018-05-08 拜耳知识产权有限责任公司 作为杀虫剂的杂环化合物
JP2013531687A (ja) 2010-07-16 2013-08-08 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリジン化合物
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
US9284310B2 (en) 2012-11-03 2016-03-15 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
EP2914592B1 (en) 2012-11-03 2017-10-11 Boehringer Ingelheim International GmbH Inhibitors of cytomegalovirus
EP2935257B1 (en) 2012-12-20 2018-02-07 Purdue Pharma LP Cyclic sulfonamides as sodium channel blockers
WO2015134711A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
EP3256461B1 (en) * 2015-02-13 2023-09-13 Azienda Ospedaliera Universitaria Senese Urea and sulfonamide derivatives as human helicase ddx3 inhibitors useful in the treatment of viral diseases
TW201729807A (zh) 2015-10-30 2017-09-01 Ｐｔｃ治療公司 用於治療癲癇的方法
EP3601274A1 (en) * 2017-03-31 2020-02-05 Perenna Pharmaceuticals, Inc. Compounds useful as inhibitors of alcat 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
PL351374A1 (en) * 1999-04-19 2003-04-07 Shionogi & Co Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
UY27263A1 (es) 2002-11-29
EP1383749B1 (de) 2005-11-02
DE50204780D1 (de) 2005-12-08
HUP0303813A3 (en) 2005-05-30
WO2002085869A1 (de) 2002-10-31
JP2004531536A (ja) 2004-10-14
JP4480941B2 (ja) 2010-06-16
RU2003133750A (ru) 2005-05-10
NO20034667D0 (no) 2003-10-17
ES2252455T3 (es) 2006-05-16
EP1383749A1 (de) 2004-01-28
CA2444123A1 (en) 2002-10-31
NO20034667L (no) 2003-12-12
US7115612B2 (en) 2006-10-03
CN1516695A (zh) 2004-07-28
HUP0303813A2 (hu) 2004-03-29
BR0209054A (pt) 2004-04-20
MXPA03009548A (es) 2004-05-24
BG108272A (bg) 2004-10-29
SK12662003A3 (sk) 2004-04-06
US20040176374A1 (en) 2004-09-09
ATE308529T1 (de) 2005-11-15
CA2444123C (en) 2010-09-21
EE200300515A (et) 2004-02-16
IL158324A0 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
IL158324A0 (en) Arylsulphonamides as anttiviral agents
WO2003016282A3 (en) Substituted 1h-dihydropyrazoles, their preparation and use
MXPA02011370A (es) Iminoazinas substituidas.
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
PL369530A1 (pl) Związki chemiczne
DK1200418T3 (da) Nematodicide trifluorbutener
AU2003228770A1 (en) Substituted pyrazolopyrimidines
PL345561A1 (en) Substituted benzoylcyclohexandiones
MY117789A (en) Pyrroloquinolones as antiviral agents
ATE297903T1 (de) Substituierte phenyluracile
MXPA02012493A (es) 1-aril-4-oxo, 1,4-dihidro-3-quinolincarboxamidas como agentes antivirales.
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
SE0101038D0 (sv) Novel compounds
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA04005988A (es) 3,4-dihidro-1h-isoquinolin-2-il-derivados.
HRP20010798B1 (hr) Postupci priprave pesticidnih međuprodukata
BR0311590A (pt) Agonistas de brs-3 não-peptìdicos
IL138638A0 (en) Processes for preparing intermediates
WO2003014094A3 (de) Heterocyclylarylsulfonamide
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
IL159493A0 (en) Pharmaceutical formulation containing an ltb4 antagonist
CA2425164A1 (en) (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists
CA2338649A1 (en) New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)